Boehringer Ingelheim and CDR-Life agree on deal worth up to $570m
The deal focuses on T cell-based therapies for autoimmune disease
Read More
Section: Healthcare
Lilly announces plan for new $3bn facility to boost manufacturing in Europe
The facility will be built in the Netherlands and will increase capacity for the company’s oral medicines portfolio
Read More
Uniphar announces US expansion and company integration
The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle
Read More
The three non-negotiable pillars of Alzheimer’s blood testing
Why sensitivity, access and education will define scalable Alzheimer’s diagnostics
Read More
Navigating the ‘Patient Metro’ – a journey full of insights
The key to unravelling its potential is to focus on the intersections where journeys are made or broken
Read More